日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HLA-B*15:01-positive severe COVID-19 patients lack CD8(+) T cell pools with highly expanded public clonotypes

HLA-B*15:01阳性的重症COVID-19患者缺乏具有高度扩增的公共克隆型的CD8(+) T细胞库

Rowntree, Louise C; Allen, Lilith F; Hagen, Ruth R; McQuilten, Hayley A; Quadeer, Ahmed A; Chaurasia, Priyanka; Kaewpreedee, Prathanporn; Lee, Kelly W K; Cohen, Carolyn A; Petersen, Jan; Littler, Dene R; Habel, Jennifer R; Zhang, Wuji; Cheng, Samuel M S; Chan, Ken Ka Pang; Kwok, Janette S Y; Leung, Kathy S M; Wu, Joseph T; Lee, Cheuk-Kwong; Davies, Jane; Pannaraj, Pia S; Kaity Allen, E; Thomas, Paul G; Tosif, Shidan; Crawford, Nigel W; Lappas, Martha; Thevarajan, Irani; Lewin, Sharon R; Kent, Stephen J; Juno, Jennifer A; Bond, Katherine A; Williamson, Deborah A; Holmes, Natasha E; Smibert, Olivia C; Gordon, Claire L; Trubiano, Jason A; Kotsimbos, Tom C; Cheng, Allen C; Efstathiou, Claudia; Turtle, Lance; Thwaites, Ryan S; Brightling, Christopher E; Rossjohn, Jamie; McKay, Matthew R; Tian, Jinmin; Liu, William Jun; Gao, George Fu; Xu, Jianqing; Sonehara, Kyuto; Ishii, Ken J; Namkoong, Ho; Okada, Yukinori; Peiris, Malik; Hui, David S C; Poon, Leo L M; Doherty, Peter C; Nguyen, Thi H O; Valkenburg, Sophie A; Kedzierska, Katherine

Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2.

抗体Fc受体结合和T细胞对同源和异源灭活疫苗或mRNA疫苗抗SARS-CoV-2免疫的反应

Cohen Carolyn A, Leung Nancy H L, Kaewpreedee Prathanporn, Lee Kelly W K, Jia Janice Zhirong, Cheung Alan W L, Cheng Samuel M S, Mori Masashi, Ip Dennis K M, Poon Leo L M, Peiris J S Malik, Cowling Benjamin J, Valkenburg Sophie A

SARS-CoV-2-specific CD8(+) T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years

来自新冠长期患者的 SARS-CoV-2 特异性 CD8(+) T 细胞可在 2 年内建立并维持效应表型和关键 TCR 特征。

Rowntree, Louise C; Audsley, Jennifer; Allen, Lilith F; McQuilten, Hayley A; Hagen, Ruth R; Chaurasia, Priyanka; Petersen, Jan; Littler, Dene R; Tan, Hyon-Xhi; Murdiyarso, Lydia; Habel, Jennifer R; Foo, Isabelle J H; Zhang, Wuji; Ten Berge, Elizabeth R V; Ganesh, Hanujah; Kaewpreedee, Prathanporn; Lee, Kelly W K; Cheng, Samuel M S; Kwok, Janette S Y; Jayasinghe, Dhilshan; Gras, Stephanie; Juno, Jennifer A; Wheatley, Adam K; Kent, Stephen J; Rossjohn, Jamie; Cheng, Allen C; Kotsimbos, Tom C; Trubiano, Jason A; Holmes, Natasha E; Pang Chan, Ken Ka; Hui, David S C; Peiris, Malik; Poon, Leo L M; Lewin, Sharon R; Doherty, Peter C; Thevarajan, Irani; Valkenburg, Sophie A; Kedzierska, Katherine; Nguyen, Thi H O

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

比较使用 CoronaVac 和 BNT162b2 (Cobovax) 进行同源和异源加强免疫的抗体和细胞介导免疫反应、反应原性和疗效:一项开放标签、随机试验

Leung, Nancy H L; Cheng, Samuel M S; Cohen, Carolyn A; Martín-Sánchez, Mario; Au, Niki Y M; Luk, Leo L H; Tsang, Leo C H; Kwan, Kelvin K H; Chaothai, Sara; Fung, Lison W C; Cheung, Alan W L; Chan, Karl C K; Li, John K C; Ng, Yvonne Y; Kaewpreedee, Prathanporn; Jia, Janice Z; Ip, Dennis K M; Poon, Leo L M; Leung, Gabriel M; Peiris, J S Malik; Valkenburg, Sophie A; Cowling, Benjamin J